215 related articles for article (PubMed ID: 31603493)
1. Dopaminergic medication reduces striatal sensitivity to negative outcomes in Parkinson's disease.
McCoy B; Jahfari S; Engels G; Knapen T; Theeuwes J
Brain; 2019 Nov; 142(11):3605-3620. PubMed ID: 31603493
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic basis for impairments in functional connectivity across subdivisions of the striatum in Parkinson's disease.
Bell PT; Gilat M; O'Callaghan C; Copland DA; Frank MJ; Lewis SJ; Shine JM
Hum Brain Mapp; 2015 Apr; 36(4):1278-91. PubMed ID: 25425542
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic drugs modulate learning rates and perseveration in Parkinson's patients in a dynamic foraging task.
Rutledge RB; Lazzaro SC; Lau B; Myers CE; Gluck MA; Glimcher PW
J Neurosci; 2009 Dec; 29(48):15104-14. PubMed ID: 19955362
[TBL] [Abstract][Full Text] [Related]
4. Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.
Christopher L; Marras C; Duff-Canning S; Koshimori Y; Chen R; Boileau I; Segura B; Monchi O; Lang AE; Rusjan P; Houle S; Strafella AP
Brain; 2014 Feb; 137(Pt 2):565-75. PubMed ID: 24334314
[TBL] [Abstract][Full Text] [Related]
5. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
Evens R; Hoefler M; Biber K; Lueken U
Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
[TBL] [Abstract][Full Text] [Related]
6. Greater striatal responses to medication in Parkinson׳s disease are associated with better task-switching but worse reward performance.
Aarts E; Nusselein AA; Smittenaar P; Helmich RC; Bloem BR; Cools R
Neuropsychologia; 2014 Sep; 62():390-7. PubMed ID: 24912070
[TBL] [Abstract][Full Text] [Related]
7. Dopamine depletion impairs gait automaticity by altering cortico-striatal and cerebellar processing in Parkinson's disease.
Gilat M; Bell PT; Ehgoetz Martens KA; Georgiades MJ; Hall JM; Walton CC; Lewis SJG; Shine JM
Neuroimage; 2017 May; 152():207-220. PubMed ID: 28263926
[TBL] [Abstract][Full Text] [Related]
8. Effects of dopamine on reinforcement learning in Parkinson's disease depend on motor phenotype.
van Nuland AJ; Helmich RC; Dirkx MF; Zach H; Toni I; Cools R; den Ouden HEM
Brain; 2020 Dec; 143(11):3422-3434. PubMed ID: 33147621
[TBL] [Abstract][Full Text] [Related]
9. Dopamine modulates striatal response to reward and punishment in patients with Parkinson's disease: a pharmacological challenge fMRI study.
Argyelan M; Herzallah M; Sako W; DeLucia I; Sarpal D; Vo A; Fitzpatrick T; Moustafa AA; Eidelberg D; Gluck M
Neuroreport; 2018 May; 29(7):532-540. PubMed ID: 29432300
[TBL] [Abstract][Full Text] [Related]
10. Impulse control disorder in Parkinson's disease is associated with abnormal frontal value signalling.
Tichelaar JG; Sayalı C; Helmich RC; Cools R
Brain; 2023 Sep; 146(9):3676-3689. PubMed ID: 37192341
[TBL] [Abstract][Full Text] [Related]
11. Dopaminergic modulation of motor network dynamics in Parkinson's disease.
Michely J; Volz LJ; Barbe MT; Hoffstaedter F; Viswanathan S; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
Brain; 2015 Mar; 138(Pt 3):664-78. PubMed ID: 25567321
[TBL] [Abstract][Full Text] [Related]
12. Cognitive states influence dopamine-driven aberrant learning in Parkinson's disease.
Cavanagh JF; Mueller AA; Brown DR; Janowich JR; Story-Remer JH; Wegele A; Richardson SP
Cortex; 2017 May; 90():115-124. PubMed ID: 28384481
[TBL] [Abstract][Full Text] [Related]
13. The effect of withdrawal of dopaminergic medication on simple and choice reaction time and the use of advance information in Parkinson's disease.
Jahanshahi M; Brown RG; Marsden CD
J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1168-76. PubMed ID: 1362212
[TBL] [Abstract][Full Text] [Related]
14. Atomoxetine restores the response inhibition network in Parkinson's disease.
Rae CL; Nombela C; Rodríguez PV; Ye Z; Hughes LE; Jones PS; Ham T; Rittman T; Coyle-Gilchrist I; Regenthal R; Sahakian BJ; Barker RA; Robbins TW; Rowe JB
Brain; 2016 Aug; 139(Pt 8):2235-48. PubMed ID: 27343257
[TBL] [Abstract][Full Text] [Related]
15. Distinct effects of apathy and dopamine on effort-based decision-making in Parkinson's disease.
Le Heron C; Plant O; Manohar S; Ang YS; Jackson M; Lennox G; Hu MT; Husain M
Brain; 2018 May; 141(5):1455-1469. PubMed ID: 29672668
[TBL] [Abstract][Full Text] [Related]
16. Dopamine controls Parkinson's tremor by inhibiting the cerebellar thalamus.
Dirkx MF; den Ouden HE; Aarts E; Timmer MH; Bloem BR; Toni I; Helmich RC
Brain; 2017 Mar; 140(3):721-734. PubMed ID: 28073788
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic therapy removal differentially effects learning in schizophrenia and Parkinson's disease.
Weickert TW; Mattay VS; Das S; Bigelow LB; Apud JA; Egan MF; Weinberger DR; Goldberg TE
Schizophr Res; 2013 Sep; 149(1-3):162-6. PubMed ID: 23830543
[TBL] [Abstract][Full Text] [Related]
18. Dose dependent dopaminergic modulation of reward-based learning in Parkinson's disease.
van Wouwe NC; Ridderinkhof KR; Band GP; van den Wildenberg WP; Wylie SA
Neuropsychologia; 2012 Apr; 50(5):583-91. PubMed ID: 22223079
[TBL] [Abstract][Full Text] [Related]
19. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
